Terms: = Uterine cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Treatment
5 results:
1. An integrative pan cancer analysis of ret aberrations and their potential clinical implications.
Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
[TBL] [Abstract] [Full Text] [Related]
2. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract] [Full Text] [Related]
3. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Bleehen NM
Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
[TBL] [Abstract] [Full Text] [Related]
4. [Effectiveness of treatment of cervical cancer using an apparatus for high-energy gamma-therapy].
Stankevich AA; Frolova ZV; Protopopov PB; Mezentseva SK; Zmeeva LV
Vopr Onkol; 1980; 26(11):59-62. PubMed ID: 6779423
[TBL] [Abstract] [Full Text] [Related]
5. Factors affecting survival in stage I and state II carcinoma of the cervix.
Welander CE; Montana GS; Saylor WL; Palumbo L; Fowler W
Obstet Gynecol; 1975 Oct; 46(4):439-43. PubMed ID: 1165880
[TBL] [Abstract] [Full Text] [Related]
